3rd Lipid Nanoparticles Development Summit Europe
Evvnt Promotion / evvnt
Archivio
24.09.2024 - 26.09.2024 Melia Berlin, 103 Friedrichstraße, 10117 Berlin, Germany
Time: 8:30 AM - 4:00 PM
Temi della conferenza
The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable.
The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2504387-3?pid=4832
Speakers: Alexander Kros, Professor, Leiden University, Christian Plank, Chief Technology Officer, Ethris, Daniel Tondera, Head of Biology, Pantherna Therapeutics, and more
Brochure: https://go.evvnt.com/2504387-3?pid=4832
Speakers: Alexander Kros, Professor, Leiden University, Christian Plank, Chief Technology Officer, Ethris, Daniel Tondera, Head of Biology, Pantherna Therapeutics, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2504387-1?pid=4832
Ms. Emily Semmens
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
